SS Innovations International (SSII) Convertible Debt (2023 - 2024)
SS Innovations International (SSII) reported Convertible Debt of $58144.0 for Q3 2024, up 71.35% sequentially from $33933.0 in Q4 2023.
SS Innovations International (SSII) Convertible Debt (2023 - 2024) Analysis & Trends
SS Innovations International (SSII) has 2 years of Convertible Debt data on file, last reported at $58144.0 in Q3 2024.
- For the quarter ending Q3 2024, Convertible Debt changed N/A year-over-year to $58144.0; the trailing twelve-month figure through Sep 2024 stood at $58144.0 (changed N/A YoY), and the FY2023 full-year result was $33933.0, changed N/A from the prior year.
- Convertible Debt improved to $58144.0 in Q3 2024, from $33933.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $58144.0 in Q3 2024 to a low of $33933.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 58,144.00 |
| Dec 31, 2023 | 33,933.00 |